The company has made it clear that animal trials start in the current quarter and finish around June.
If those trials do confirm that Myc can be temporarily switched off with a proprietary phylomer in blood, then big pharma will want this science at a very, very handsome premium, that could ultimately be measured in the 100's $millions, not in the 10's of $millions
Any switching off of Myc will have applications for many other cancer drugs as dosage can be reduced and many less side effects.
Very happy to now wait a few months for those results and I'm not at all surprised some smarties waking up to the potential.
Good luck now getting volume at these levels boys.
RH will have been presenting to many pros at the bio conference in US last week.
PYC Price at posting:
1.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)